An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumours

Trial Centre Location Province Status
Princess Margaret Cancer Centre Toronto Ontario Pending
CHU de Québec - Université Laval - L'Hôtel-Dieu de Québec Quebec Quebec Recruiting

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.

Resources

Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society